CONTINUING MEDICAL EDUCATION

SELNET Webinars

This webinar focused on GIST updates and was organized by the GIST working group and moderated by Drs. Matías Chacón and Javier Martín. Take advantage of the opportunity to enjoy talks from our experts: Drs. Munhoz and Dr. Trent. Note: Dr. Bauer’s talk is not included in the recording as it contained copyrighted footage that did not permit public dissemination.

The webinar was held on Thursday, May 8, from 4:00 PM to 5:30 PM (CET).

This webinar focused on TGCT (Giant Tendon Cell Tumour), was organised by the Local Extremities Working Group, with the participation of Drs. Eduardo Ortiz, Marthelena Acosta, Carlos Andres Lores and Nadia Hindi and moderated by Dr. Marcos Galli.

The webinar was held on 3, July, from 13:00 to 14.30 (CET).

SELNET Meetings

Las ponencias para las que hemos recibido autorización ya están disponibles.

👉 Puedes acceder a ellas aquí:

CASO CLINICO_Kevin Fernando Reyna Perez

SARCOMAS EN ADOLESCENTES Y ADULTOS JÓVENES_Marco Rodrigo Aguilar Ortiz

NEW COMBINATION STRATEGIES_Salvatore Provenzano

DECISIONES QUIRÚRGICAS Y FUNCIONALIDAD EN SARCOMAS DE AYA- PRESERVACIÓN Y RADICALIDAD_Ana Paula Meléndez

SARCOMAS PACIENTES JÓVENES-DIAGNÓSTICO Y NUEVAS ENTIDADES_Rodolfo Guzmán Cervantes

ESTRATEGIAS LOCORREGIONALES EN ENFERMEDAD OLIGOMETASTASIS Y OLIGOPROGRESORAS_Dorian García Ortega

NUEVAS ESTRATEGIAS TERAPÉUTICAS TRATAMIENTOS SISTÉMICOS CON ÉNFASIS A LA NEOADYUVANCIA_Nadia Hindi Muñiz

TUMOR DESMOIDE DEL QUIROFANO AL CONTROL MOLECULAR_EL NUEVO PARADIGMA_Matias Chacon

_____________________________________________

Concurso Trabajos libres // Call Competition for free works

Puedes consultar la tabla de puntuaciones y criterios de evaluación / You can view the full scoring table and evaluation criteria:

Bases de participación//Participation bases

Evaluación trabajos del XII Simposio SELNET-INCan (México).docx

_____________________________________________

Winners of the Abstracts/Posters Call

  • Natalia Vázque Flores – Award for Best Abstract entitled “Hereditary cancer and sarcomas: molecular characterization of a Latin American cohort from a national cancer center (2016-2024).” (€2,000)
  • Gisel Vera Rodriguez – Award for Best Abstract entitled “Impact of plasma levels of imatinib on survival in patients undergoing adjuvant treatment for gastrointestinal stromal tumors” (€1,000)

The papers for which we have received permission are now available.

👉 You can access them here:

Can UPS diagnosis be made more precise?_Alberto Righi

First line treatment in patients with advanced leiomyosarcoma Single agent or combination? An old question with new options _Nadia Hindi and Jonathan Trent

Clinical and pathological challenging cases with discussion_Lucia Gonzalez, Salvatore Provenzano, Marina Pacheco and Bruna David

Best sequence of systemic therapy for metastatic MPNST_Shreyaskumar Patel

Perioperative systemic therapy in high-risk soft tissue sarcoma Yes or Not: “Game of thrones I”_Shreraskumar Patel

Ultra rare sarcomas with ultra specific treatments: A journey from GIST to TGCT_Bruna David

_____________________________________________

Call Competition for free works

You can view the full scoring table and evaluation criteria:

Participation bases

Abstracts_ Posters_Evaluation_XIII SELNET Annual Meeting 2025

_____________________________________________

Cellso Mello Grant 2025

You can view the full scoring table and evaluation criteria:

Participation base_Celso Mello Grant_2025

Celso_Mello_Grant_2025_Evaluation

_____________________________________________

Winners of the Abstracts/Posters Call

  • Mariana Souza – Premio al Mejor Abstract titulado “Somatic alterations and prognostic markers in chondrosarcoma: insights from a brazilian cohort” (2.000 €)
  • Ricardo Clairefont Dias Regis – Premio al Mejor Abstract titulado “Long-Term Survival and Recurrence in Myxofibrosarcoma: Insights from a 24-Year Patient Cohort” (1.000 €)

Winner of Celso Mello Grant 2025

  • Eloy Andres Pérez Yepez for his study entitled “Targeting BUB1 in Patient-Derived Tumor Organoids (PDTOs): A Preclinical Study in Osteosarcoma and Leiomyosarcoma.” This award is granted with €15,000.